Immune Checkpoint Inhibitors in Real‐World Treatment of Older Adults with Non–Small Cell Lung Cancer.

MLA

Muchnik, Eugene, et al. “Immune Checkpoint Inhibitors in Real‐World Treatment of Older Adults with Non–Small Cell Lung Cancer.” Journal of the American Geriatrics Society, vol. 67, no. 5, May 2019, pp. 905–12. EBSCOhost, https://doi.org/10.1111/jgs.15750.

APA

Muchnik, E., Loh, K. P., Strawderman, M., Magnuson, A., Mohile, S. G., Estrah, V., & Maggiore, R. J. (2019). Immune Checkpoint Inhibitors in Real‐World Treatment of Older Adults with Non–Small Cell Lung Cancer. Journal of the American Geriatrics Society, 67(5), 905–912. https://doi.org/10.1111/jgs.15750

Chicago

Muchnik, Eugene, Kah Poh Loh, Myla Strawderman, Allison Magnuson, Supriya G. Mohile, Vered Estrah, and Ronald J. Maggiore. 2019. “Immune Checkpoint Inhibitors in Real‐World Treatment of Older Adults with Non–Small Cell Lung Cancer.” Journal of the American Geriatrics Society 67 (5): 905–12. doi:10.1111/jgs.15750.